register now
get brochure
add event to diary
email this to...
contact us
Breakthrough
Contact LIVE

conference details
 
Conference:
Day 1
17 March 2010 8am - 5:30pm
Day 2
18 March 2010 8am - 5:30pm

› More about the conference
› Add this to my calendar

Register online now
or call +65 6322 2701

 

 

 

Mr Israel Makov, speaking at Drug Discovery Technology World Asia 2010

Mr Israel Makov,
Chairman
Given Imaging, Chairman, Netafim, Former President and Chief Executive Officer, Teva Pharmaceutical , Israel

Israel Makov is the former President & CEO of Teva Pharmaceutical Industries Ltd., and is widely credited with making the company the world’s leader in the generic industry. Since he joined Teva in 1995, Makov led the company’s global expansion, managing over 12 acquisitions—including the acquisition of Ivax for $7.8 billion, then the largest M&A deal in Israeli history. During Makov’s five year tenure as CEO, the company’s sales increased over four-fold, and its adjusted net income increased approximately six-fold. Today, Makov is Chairman of Given Imaging—the pioneer developer and world leading provider of capsule endoscopy and Chairman of Netafim—the global leader in smart irrigation solutions Formerly, Makov led a number of companies in various industries, including founding Israel’s first biotech company, Interpharm, which went public in the US. Makov is a member of the Board of Directors of the Israel National Nanotechnology Initiative, an initiative he also helped found. He is also a member of the Executive Board & Management Committee of the Weizmann Institute of Science, on the Board of Governors of the Technion – Israel Institute of Technology, the Chairman of the Board of the Institute for Policy and Strategy at the Interdisciplinary Center of Herzliya, the President of the Friends of Schneider Children’s Medical Center of Israel and also the Chairman of the Friends of Gesher Theatre, one of Israel’s leading theaters. Mr Makov holds a B.Sc. in Agriculture, and M.Sc. in Economics from the Hebrew University, Jerusalem.
Appearing:
Conference Day One: Wednesday, 17 March 2010
09.00

Cultivating entrepreneurships in biopharmaceutical industry of Asia and beyond

Entrepreneurship, whether being a start-up or within an organization, is a key driver of our economy. Wealth and a high majority of jobs are created by small businesses started by entrepreneurially minded individuals, many of whom go on to create big businesses. Gearing up for a global gravity shift towards Asia, biopharma entrepreneurs are facing a wealth of opportunities. What are the success factors that Asia’s emerging biopharma business leaders employ to capture the growth of the industry? Find out the trade secrets when we take you through the journey of entrepreneurship with the most successful entrepreneurs from Asia
  • The promises and challenges of Asia’s biopharmaceutical market in an era of healthcare reform
  • Looking into the business opportunities in Asia to drive growth and global expansion for Asian and global players
  • Finding the right business model and strategy to achieve success in the Asian and global biopharmaceutical arena
Mr Peter Kash,
(Moderator)
President,
Riverbank Capital Securities, United States of America
Mr Israel Makov,
Chairman,
Given Imaging, Chairman, Netafim, Former President and Chief Executive Officer, Teva Pharmaceutical , Israel
Founder, Chairperson & Managing Director,
Avesthagen Limited, India
part of:

event sponsors
Session sponsor:
 
Exhibitors:
 
 
 

asia research institution poster presentation


Present a poster and get free passes* to attend Drug Discovery Technology World Asia 2010 symposium and Pharma R&D Partnering World Asia 2010!
 
* For first 20 confirmed poster presentations

sponsorship opportunities
Drug Discovery Technology World Asia 2010 is your gateway to doing business with people who can make procurement decisions in the booming industry of Asia!
 
Demonstrate your thought leadership, reinforce with proven case studies, put forward your lead scientists and associate your brand with the industry’s FIRST and BEST forum to discuss challenges, solutions, best practices and business opportunities!
 
 
Target your market!
 
Contact us for details
 


comment / report a mistake | contact us | about Terrapinn | site map | privacy | T&Cs a terrapin ©Terrapinn Holdings Ltd. MMX